BioSpace News Archive

BioSpace looks at five of the top investor companies that support life sciences companies across the industry.

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

KAHR and Cancer Focus Fund, LP, a unique venture capital fund established in collaboration with The University of Texas MD Anderson Cancer Center to provide funding and clinical expertise to advance promising cancer therapies, announced that Cancer Focus Fund is investing $5 million to finance a clinical trial of KAHR’s lead anti-CD47 candidate, DSP107, in blood cancers.

Three patent families have been filed to cover novel hormonal combinations: pramlintide-exenatide and glucagon-exenatide – both combinations demonstrated promising effects in obesity treatment

OSE Immunotherapeutics announced that the first healthy volunteer has been enrolled and dosed in the Phase 1 clinical trial evaluating its COVID-19 vaccine, named CoVepiT.

Nordic Nanovector ASA announces its results for the first quarter 2021. A live webcast presentation by Nordic Nanovector’s management team will take place at 08.30 CEST.

The U.S. Food and Drug Administration granted orphan drug designation to Tesomet for the treatment of Prader-Willi syndrome (PWS). This designation qualifies Saniona for certain development benefits, including tax credits, elimination of certain FDA license application fees, and seven years of market exclusivity in the U.S. following approval.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for inflammatory diseases and cancers, provided an update on further analysis of lymphocyte subsets from blood samples from a Phase 1 study with nasally administered Foralumab in healthy volunteers.

Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has published the report for the first quarter 2021.

The Treponema pallidum molecule agglutination examine is a circuitous agglutination measure used to identify and titrate antibodies in contrast to the causative specialist of syphilis, called Treponema pallidum which is a subspecies pallidum.